Difference between revisions of "Aspirin and dipyridamole (Aggrenox)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| Line 11: | Line 11: | ||
[[Category:Antipyretics]] | [[Category:Antipyretics]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1999]] |
[[Category:FDA approved drugs]] | [[Category:FDA approved drugs]] | ||
Revision as of 19:27, 30 July 2018
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 25 mg of aspirin, as an immediate-release sugar-coated tablet.
Also known as
- Brand name: Aggrenox